Endocrinology Research and Practice
Reviews

Diabetic Osteodystrophy

1.

Department of Endocrinology, School of Medicine, Lokman Hekim University, Ankara, Türkiye

2.

Department of Endocrinology, School of Medicine, Bursa Uludağ University, Bursa, Türkiye

Endocrinol Res Pract 2024; 28: 175-180
DOI: 10.5152/erp.2024.24463
Read: 407 Downloads: 199 Published: 03 July 2024

Abstract: Diabetes mellitus (DM) is associated with an increased risk of fractures due to deterioration of bone quality, which can be referred to as “diabetic osteodystrophy.” Furthermore, the risk of fracture is increased in DM, even if bone mineral density is normal or high and is associated with increased morbidity if a fracture develops. In addition to the pathophysiological mechanisms of DM, diabetesrelated complications and drugs used in the treatment of DM may also affect bone health. Moreover, the increased risk of falling due to microvascular complications, hypoglycemia, and postural hypotension also contributes to the development of fractures. Individuals with DM should be screened for osteoporosis with recommendations similar to those of the general population. When diagnosing osteoporosis and deciding on treatment, it should be kept in mind that DM may be an important risk factor, and lower threshold values of the T score should be used.

Cite this article as: Eren MA, Öz Gül Ö. Diabetic osteodystrophy. Endocrinol Res Pract. 2024;28(3):175-180.

Files
EISSN 2822-6135